» Articles » PMID: 33893246

The Effect of IL-6/Piezo2 on the Trigeminal Neuropathic Pain

Overview
Specialty Geriatrics
Date 2021 Apr 24
PMID 33893246
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The nature of trigeminal neuropathic pain (TN) attacks is regarded as the ignition of ectopic action potentials from the trigeminal root following vascular compression, which seemed to be related to transmembrane proteins and inflammation factors. This study focused on the mechanosensitive channel Piezo2 and cytokine IL-6. The chronic constriction injury of infraorbital nerve in SD rats was used to establish the TN model. The trigeminal ganglion was then achieved to perform immunocytochemistry studies. A significant upregulation of Piezo2 and IL-6 was showed in the TN model rats. The Piezo2 positive accounted for 72.3±9.5% in those IL-6 positive neurons. The Piezo2 co-localized with CGRP, IB4 and NF-200 but not with GFAP, which implied that it was expressed in both the C-type and the A-type neurons. After administration of GsMTx4 or anti-rat IL-6 antibody in the TN model, the dynamic allodynia and pinprick hyperalgesia scores as well as the mechanical threshold changed significantly. In the sham-operation rates, with local administration of IL-6, an upregulation of Piezo2 was also exhibited. Our study demonstrated that the up-regulation of Piezo2 in the pain afferent neurons following trigeminal nerve injury may play a role in the development of the neuralgia. Meanwhile, the expression of Piezo2 may be modulated by inflammatory cytokines, such as IL-6.

Citing Articles

TET1 participates in oxaliplatin-induced neuropathic pain by regulating microRNA-30b/Nav1.6.

Zhao S, Zhang J, Zhang M, Yang Q, Li Z, Ren X J Biol Chem. 2025; 301(3):108228.

PMID: 39864621 PMC: 11894311. DOI: 10.1016/j.jbc.2025.108228.


Emerging Psychotropic Drug for the Treatment of Trigeminal Pain: Salvinorin A.

Quinonez-Bastidas G, Grijalva-Contreras L, Patino-Camacho S, Navarrete A Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770461 PMC: 11728561. DOI: 10.3390/ph17121619.


The Role of Mechanosensitive Piezo Channels in Chronic Pain.

Wan Y, Zhou J, Li H J Pain Res. 2024; 17:4199-4212.

PMID: 39679432 PMC: 11646438. DOI: 10.2147/JPR.S490459.


Piezo channels in JG cells do not regulate renin expression or renin release to the circulation.

Nagalakshmi V, Smith J, Matsuoka D, Gomez R, Sequeira-Lopez M Clin Sci (Lond). 2024; 138(23):1527-1536.

PMID: 39564667 PMC: 11843579. DOI: 10.1042/CS20242089.


Blockade of Piezo2 Pathway Attenuates Inflammatory and Neuropathic Pain in the Orofacial Area.

Jo M, Son J, Kim Y, Ju J, Park M, Lee M Pain Res Manag. 2024; 2024:9179928.

PMID: 39372838 PMC: 11452243. DOI: 10.1155/2024/9179928.


References
1.
Alcaino C, Knutson K, Gottlieb P, Farrugia G, Beyder A . Mechanosensitive ion channel Piezo2 is inhibited by D-GsMTx4. Channels (Austin). 2017; 11(3):245-253. PMC: 5463886. DOI: 10.1080/19336950.2017.1279370. View

2.
Park S, Kim B, Koo J, Cho H, Lee C, Kim M . A tarantula spider toxin, GsMTx4, reduces mechanical and neuropathic pain. Pain. 2008; 137(1):208-217. DOI: 10.1016/j.pain.2008.02.013. View

3.
Bennett G, Chung J, Honore M, Seltzer Z . Models of neuropathic pain in the rat. Curr Protoc Pharmacol. 2011; Chapter 5:Unit5.32. DOI: 10.1002/0471141755.ph0532s21. View

4.
Zigmond R . gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury. Front Mol Neurosci. 2012; 4:62. PMC: 3262188. DOI: 10.3389/fnmol.2011.00062. View

5.
Maarbjerg S, Stefano G, Bendtsen L, Cruccu G . Trigeminal neuralgia - diagnosis and treatment. Cephalalgia. 2017; 37(7):648-657. DOI: 10.1177/0333102416687280. View